Courageous
Science +
Compassion

Leading the way in complement science for patients

NEWS

Apellis Announces FDA Acceptance of NDA Amendment and New PDUFA Date of February 26, 2023 for Pegcetacoplan for Geographic Atrophy (GA)
All news

Our Pipeline We aim to transform treatment across a
broad range of debilitating diseases driven by complement »

We Replace
Impossible with How

We challenge conventional thinking and always question if there's a better way.

Join the Team